Charles Schwab Investment Management Inc Pulse Biosciences, Inc. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 148,114 shares of PLSE stock, worth $2.71 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

148,114

Previous 50,549 193.01%

Holding current value

$2.71 Million

Previous $565,000 359.65%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$10.83 - $21.83 $1.06 Million - $2.13 Million	97,565 Added 193.01%	148,114 $2.6 Million
Q2 2024 Aug 12, 2024	BUY	$6.69 - $14.54 $45,853 - $99,657	6,854 Added 15.69%	50,549 $565,000
Q2 2023 Aug 09, 2023	BUY	$3.67 - $8.64 $160,360 - $377,524	43,695 New	43,695 $314,000
Q2 2022 Aug 15, 2022	SELL	$1.48 - $4.28 $45,554 - $131,738	-30,780 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$4.21 - $14.79 $22,371 - $78,594	-5,314 Reduced 14.72%	30,780 $150,000
Q4 2021 Feb 11, 2022	BUY	$14.78 - $24.4 $22,761 - $37,576	1,540 Added 4.46%	36,094 $535,000
Q3 2021 Nov 16, 2021	SELL	$17.25 - $26.63 $4,450 - $6,870	-258 Reduced 0.74%	34,554 $747,000
Q2 2021 Aug 16, 2021	SELL	$16.31 - $23.64 $13,276 - $19,242	-814 Reduced 2.28%	34,812 $571,000
Q1 2021 May 17, 2021	BUY	$22.43 - $44.27 $45,263 - $89,336	2,018 Added 6.0%	35,626 $844,000
Q4 2020 Feb 16, 2021	BUY	$11.66 - $24.5 $28,053 - $58,947	2,406 Added 7.71%	33,608 $802,000
Q3 2020 Nov 13, 2020	SELL	$9.27 - $13.14 $16,055 - $22,758	-1,732 Reduced 5.26%	31,202 $368,000
Q2 2020 Aug 14, 2020	BUY	$6.23 - $13.09 $37,012 - $77,767	5,941 Added 22.01%	32,934 $345,000
Q2 2019 Aug 09, 2019	BUY	$11.11 - $17.34 $20,586 - $32,131	1,853 Added 7.37%	26,993 $357,000
Q1 2019 May 14, 2019	BUY	$11.69 - $19.44 $26,185 - $43,545	2,240 Added 9.78%	25,140 $443,000
Q4 2018 Feb 14, 2019	BUY	$9.08 - $14.34 $27,240 - $43,020	3,000 Added 15.08%	22,900 $263,000
Q3 2018 Nov 13, 2018	BUY	$12.83 - $16.45 $57,735 - $74,025	4,500 Added 29.22%	19,900 $283,000
Q2 2018 Aug 08, 2018	BUY	$14.04 - $20.28 $1,404 - $2,028	100 Added 0.65%	15,400 $234,000
Q3 2017 Nov 13, 2017	BUY	$10.26 - $24.97 $156,978 - $382,041	15,300	15,300 $285,000

Others Institutions Holding PLSE

# of Institutions

Shares Held

5.41M

Call Options Held

139K

Put Options Held

84.2K

View Full List

About Pulse Biosciences, Inc.

Ticker PLSE
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 37,125,900
Market Cap $679M
Description
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...

More about PLSE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Pulse Biosciences, Inc. Transaction History